| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $56.6M | +50.1% |
| SG&A Expense | $26.4M | +63.8% |
| Operating Income | -$83.1M | -54.2% |
| Pre-tax Income | -$77.4M | -49.0% |
| Income Tax | $0 | — |
| Net Income | -$77.4M | -49.0% |
| EPS (Basic) | -$2.52 | -18.9% |
| EPS (Diluted) | -$2.52 | -18.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.6M | +38.7% |
| Short-term Investments | $75.3M | -7.3% |
| Current Assets | $106.6M | +0.3% |
| Total Assets | $107.4M | -0.7% |
| Current Liabilities | $18.2M | +155.2% |
| Total Liabilities | $18.8M | +129.2% |
| Stockholders' Equity | $88.6M | -11.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$63.7M | -34.5% |
| Capital Expenditures | $221K | -36.1% |
| Investing Cash Flow | $10.5M | +118.2% |
| Financing Cash Flow | $60.9M | — |
| Free Cash Flow | -$63.9M | -33.9% |